| CTCF |
HeLa (cervical adenocarcinoma) |
Plasmids: pGK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-CCDC85C_3-gRNA-GFP |
Permissive
Robust
|
Homo sapiens |
GSE107607
...
|
MA0139.1
|
| CTCF |
HeLa (cervical adenocarcinoma) |
Plasmids: pGK-dCas9-SunTag (Addgene #100943) + pEF1a-NLS-scFvGCN4-DNMT3A (Addgene #100941) + pEf1a-MIR152-gRNA-GFP |
Permissive
Robust
|
Homo sapiens |
GSE107607
...
|
MA0139.1
|
| CTCF |
HeLa S3 (cervical adenocarcinoma) |
treatment: no block with TSA CellPopulation:synchronized |
Permissive
Robust
|
Homo sapiens |
GSE108173
...
|
MA0139.1
|
| CTCF |
HeLa S3 (cervical adenocarcinoma) |
treatment: no block with TSA CellPopulation:synchronized |
Permissive
Robust
|
Homo sapiens |
GSE108173
...
|
MA0139.1
|
| CTCF |
HeLa S3 (cervical adenocarcinoma) |
treatment: no block with TSA CellPopulation:unsynchronized |
Permissive
Robust
|
Homo sapiens |
GSE108173
...
|
MA0139.1
|
| CTCF |
HeLa S3 (cervical adenocarcinoma) |
treatment: no block with TSA CellPopulation:unsynchronized |
Permissive
Robust
|
Homo sapiens |
GSE108173
...
|
MA0139.1
|
| CTCF |
LUHMES (lund human mesencephalic cells) |
Sex: female Passages: 3-10 Stage: neural progenitor cells, undifferentiated Treatment: Prior to differentiation, cells were seeded at 3.5 x 10^6 per T75 flask containing complete growth medium and incubated at 37 °C for 24 hr |
Permissive
Robust
|
Homo sapiens |
GSE109706
...
|
MA0139.1
|
| CTCF |
LUHMES (lund human mesencephalic cells) |
Sex: female Passages: 3-10 Stage: dopaminergic neurons, differentiated Treatment: For induction of differentiation, culture medium was changed to freshly prepare DMEM:F12 with 2 mM L-glutamine, 1X N-2, 1 mM cAMP (Carbosynth, Cat # ND07996), 1 mg/mL tetracycline (Sigma, Cat # T7660), and 2 ng/mL glial cell line-derived neurotrophic factor (GDNF) (Sigma, Cat # G1777) |
Permissive
Robust
|
Homo sapiens |
GSE109706
...
|
MA0139.1
|
| CTCF |
MDM(monocyte derived macrophages) |
Treatment: mock infected, time post infection 24 hr |
Permissive
Robust
|
Homo sapiens |
GSE118305
...
|
MA0139.1
|
| CTCF |
MDM(monocyte derived macrophages) |
Treatment: ZIKV-bystander, time post infection 24 hr ViralStrain: ZIKV-FSS13025 |
Permissive
Robust
|
Homo sapiens |
GSE118305
...
|
MA0139.1
|